175 related articles for article (PubMed ID: 10459165)
21. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
Reinsch B; Zimmy S; Schatz H; Pfohl M
Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
[TBL] [Abstract][Full Text] [Related]
22. Cross-reactive peptide epitopes of Enterovirus Coxsackie B4 and human glutamic acid decarboxylase detecting antibodies in latent autoimmune diabetes in adults versus type 1 diabetes.
Real-Fernández F; Gallo A; Nuti F; Altamore L; Del Vescovo GG; Traldi P; Ragazzi E; Rovero P; Lapolla A; Papini AM
Clin Chim Acta; 2021 Apr; 515():73-79. PubMed ID: 33422493
[TBL] [Abstract][Full Text] [Related]
23. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
Lindholm E; Hallengren B; Agardh CD
Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
[TBL] [Abstract][Full Text] [Related]
24. Coxsackievirus immunization delays onset of diabetes in non-obese diabetic mice.
Davydova B; Härkönen T; Kaialainen S; Hovi T; Vaarala O; Roivainen M
J Med Virol; 2003 Apr; 69(4):510-20. PubMed ID: 12601759
[TBL] [Abstract][Full Text] [Related]
25. [Antibody levels against coxsackie B viruses in patients with type 1 diabetes mellitus].
Emekdaş G; Rota S; Kuştimur S; Kocabeyoğlu O
Mikrobiyol Bul; 1992 Apr; 26(2):116-20. PubMed ID: 1316989
[TBL] [Abstract][Full Text] [Related]
26. [Study on specificity of IgM antibody response in patients with coxsackie virus B infection].
Zhang T; Ma G; Ma L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):66-8. PubMed ID: 12526307
[TBL] [Abstract][Full Text] [Related]
27. [Coxsackie B4 and cytomegalovirus in patients with insulin-dependent diabetes].
Pato E; Cour MI; González Cuadrado S; González Gómez C; Muñoz JJ; Figueredo A
An Med Interna; 1992 Jan; 9(1):30-2. PubMed ID: 1313709
[TBL] [Abstract][Full Text] [Related]
28. [Prevalence of anti-GAD autoantibodies in Tunisian children with type 1 diabetes].
Elkadhi A; Khelifi N; Abid A; Nagati K; Jenhani F; Ben Rayana MC
Tunis Med; 2002 May; 80(5):281-5. PubMed ID: 12534034
[TBL] [Abstract][Full Text] [Related]
29. Characterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetes.
Khan MW; Sherwani S; Khan WA; Ali R
Autoimmunity; 2009 Feb; 42(2):150-8. PubMed ID: 19085183
[TBL] [Abstract][Full Text] [Related]
30. Type 1 diabetes and Coxsackie virus infection.
Di Pietro C; Del Guercio MJ; Paolino GP; Barbi M; Ferrante P; Chiumello G
Helv Paediatr Acta; 1979; 34(6):557-61. PubMed ID: 232095
[TBL] [Abstract][Full Text] [Related]
31. Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes.
Narendran P; Williams AJ; Elsegood K; Leech NJ; Dayan CM
Diabetes Metab Res Rev; 2003; 19(1):52-9. PubMed ID: 12592644
[TBL] [Abstract][Full Text] [Related]
32. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes.
Atkinson MA; Bowman MA; Campbell L; Darrow BL; Kaufman DL; Maclaren NK
J Clin Invest; 1994 Nov; 94(5):2125-9. PubMed ID: 7962558
[TBL] [Abstract][Full Text] [Related]
33. Incomplete immune response to coxsackie B viruses associates with early autoimmunity against insulin.
Ashton MP; Eugster A; Walther D; Daehling N; Riethausen S; Kuehn D; Klingel K; Beyerlein A; Zillmer S; Ziegler AG; Bonifacio E
Sci Rep; 2016 Sep; 6():32899. PubMed ID: 27604323
[TBL] [Abstract][Full Text] [Related]
34. Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies.
Franke B; Galloway TS; Wilkin TJ
Diabetes Metab Res Rev; 2005; 21(5):395-415. PubMed ID: 15895384
[TBL] [Abstract][Full Text] [Related]
35. [Demonstration and immunologic effect of an infection of the human thymus by the diabetogenic human Coxsackievirus B4].
Brilot F
Bull Mem Acad R Med Belg; 2003; 158(5-6):277-83. PubMed ID: 15025268
[TBL] [Abstract][Full Text] [Related]
36. Gene-gun biolistic immunization encoding glutamic acid decarboxylase: a model for studying Langerhans cell abnormalities and mimicry in the nonobese diabetic mouse.
Joussemet B; Vu AT; Sai P; Bach JM
Ann N Y Acad Sci; 2005 Jun; 1051():613-25. PubMed ID: 16127002
[TBL] [Abstract][Full Text] [Related]
37. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
[TBL] [Abstract][Full Text] [Related]
38. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
[TBL] [Abstract][Full Text] [Related]
39. [Auto-antibodies against glutamic acid decarboxylase and diabetes].
Mandrup-Poulsen TR
Ugeskr Laeger; 2007 Jan; 169(4):300-4. PubMed ID: 17274923
[TBL] [Abstract][Full Text] [Related]
40. Peptide Antibody Reactivity to Homologous Regions in Glutamate Decarboxylase Isoforms and Coxsackievirus B4 P2C.
Trier NH; Valdarnini N; Fanelli I; Rovero P; Hansen PR; Schafer-Nielsen C; Ciplys E; Slibinskas R; Pociot F; Friis T; Houen G
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
